Company news
CSL Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Update - Notification of buy-back - CSL
November 19, 2026
Update - Notification of buy-back - CSL
November 18, 2026
Update - Notification of buy-back - CSL
November 17, 2026
Update - Notification of buy-back - CSL
November 16, 2026
Update - Notification of buy-back - CSL
November 15, 2026
Update - Notification of buy-back - CSL
November 12, 2026
Update - Notification of buy-back - CSL
November 11, 2026
Update - Notification of buy-back - CSL
November 10, 2026
Update - Notification of buy-back - CSL
November 9, 2026
Update - Notification of buy-back - CSL
November 8, 2026
Notification of cessation of securities - CSL
November 6, 2026
Update - Notification of buy-back - CSL
November 5, 2026
Update - Notification of buy-back - CSL
November 4, 2026
Update - Notification of buy-back - CSL
November 1, 2026
Update - Notification of buy-back - CSL
October 29, 2026
CSL 2026 AGM Results of Meeting
October 26, 2026
CSL Limited Annual General Meeting 2026
October 26, 2026
Brian McNamee to retire Gordon Naylor appointed next Chair
October 25, 2026
CSL to Defend Class Action
October 21, 2026
CSL to Defend Class Action
October 21, 2026
CSL appoints Deborah Waterhouse as CEO & Managing Director
October 21, 2026
Appointment of New CEO
October 21, 2026
Appointment of New CEO
October 21, 2026
Update on U.S. Plasma Collection Network
October 8, 2026
CSL dan Alentis umum perkongsian global untuk membangunkan dan mengkomersialkan lixudebart bagi penyakit buah pinggang dan hati yang jarang berlaku
October 8, 2026
CSL prices US$1.5 billion in Corporate Bonds
October 6, 2026
CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
October 4, 2026
CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยาก
October 5, 2026
CSL enters exclusive agreement with Alentis Therapeutics
October 4, 2026
CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
September 29, 2026
Update - Notification of buy-back - CSL
September 23, 2026
Update - Notification of buy-back - CSL
September 22, 2026
UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu vaccine (aTIVc) and Extending Health Security Pandemic Agreement
September 21, 2026
Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks
September 22, 2026
Update - Notification of buy-back - CSL
September 21, 2026
Update - Notification of buy-back - CSL
September 17, 2026
Update - Notification of buy-back - CSL
September 16, 2026
Notice of Meeting and Shareholder Pack 2026
September 16, 2026
Update - Notification of buy-back - CSL
September 15, 2026
Update - Notification of buy-back - CSL
September 14, 2026
Update - Dividend/Distribution - CSL
September 13, 2026
Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
September 10, 2026
Update - Notification of buy-back - CSL
September 8, 2026
Application for quotation of securities - CSL
September 8, 2026
Notification regarding unquoted securities - CSL
September 8, 2026
Notification of cessation of securities - CSL
September 7, 2026
Notification of cessation of securities - CSL
September 3, 2026
Application for quotation of securities - CSL
September 3, 2026
Change in substantial holding
September 3, 2026
Appendix 3Y - Alison Watkins AM
September 3, 2026
Calls
The 5 newest of 8 calls. Every call is listed under its year.
- CSL (ASX:CSL) Q4 2026 Earnings Call
Aug 19, 2026
Transcript - CSL (ASX:CSL) Q2 2026 Earnings Call
Feb 10, 2026
Transcript - CSL (ASX:CSL) Q4 2025 Earnings Call
Aug 19, 2025
Transcript - CSL (ASX:CSL) Q2 2025 Earnings Call
Feb 11, 2025
Transcript - CSL (ASX:CSL) Q4 2024 Earnings Call
Aug 13, 2024
Transcript
Decks
The 5 newest of 115 decks. Every deck is listed under its year.
- Shareholder Meeting (October 2026)
Shareholder meeting · 26 slides · Oct 27, 2026
- FY2026 Earnings Presentation
Earnings · 32 slides · Aug 18, 2026
- H1 FY2026 Earnings Presentation
Earnings · 26 slides · Feb 11, 2026
- Investor Day (November 2025)
Investor day · 76 slides · Nov 5, 2025
- Investor Day (November 2025)
Investor day · 20 slides · Nov 5, 2025